Home › Funds › Fideuram Asset Management (Ireland) dac › ABT

Fideuram Asset Management (Ireland) dac position in ABT

ABBOTT LABORATORIES · Health Care

Fideuram Asset Management (Ireland) dac reported holding 175,354 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$18.2M, representing 0.40% of its reported portfolio and ranking #48 among its reported holdings. Fideuram Asset Management (Ireland) dac has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)175.35K sh
Reported value held$18.21M
Portfolio Weight0.40%
First reportedQ4 2025
Last changeAdd
Updated2026-10-29

Last updated: 2026-10-29 · Source: SEC EDGAR Form 13F-HR

How Fideuram Asset Management (Ireland) dac's ABT position evolved

Fideuram Asset Management (Ireland) dac first disclosed a stake in ABT in Q4 2025 at 20,866 shares (US$2.8M). The position peaked in Q3 2026 at 175,354 shares, worth US$18.2M. Across 4 filings, Fideuram Asset Management (Ireland) dac increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 175,354 shares valued at US$18.2M — an increase of 25,950 shares quarter over quarter.. Notable position changes include a 90% trim in Q1 2026 (shares fell 11% over the following quarter), a 6722% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 20.87K $2.84M New
Q1 2026 2.19K $243.24K Reduce
Q2 2026 149.40K $13.35M Add
Q3 2026 175.35K $18.21M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Fideuram Asset Management (Ireland) dac held ABT?

Fideuram Asset Management (Ireland) dac has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Fideuram Asset Management (Ireland) dac's current position in ABT?

As of Q3 2026, Fideuram Asset Management (Ireland) dac holds 175.35K shares of ABT (ABBOTT LABORATORIES), valued at $18.21M, representing 0.40% of its reported portfolio and ranking #48.

Has Fideuram Asset Management (Ireland) dac been buying or selling ABT?

In the latest 13F filing (Q3 2026), Fideuram Asset Management (Ireland) dac increased its position in ABT. The position peaked in Q3 2026 at 175.35K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.